FDA Approves STS101 Nasal Powder as New Treatment for Acute Migraine
Breaking Barriers in Stroke Care: Insights From SEQUINS Hall of Famer Lewis B. Morgenstern, MD
Honoring 2025 SEQUINS Hall of Famers: Perspectives From Cheryl Bushnell, MD, MHS
Vidofludimus Calcium Demonstrates Therapeutic Potential in Latest Phase 2 CALLIPER Trial Data of Progressive Multiple Sclerosis